Strategizing The Scale-Up Of Cell Therapy Manufacturing Capacity

By Michelle Raley

Adaptimmune is one of the only cell therapy companies that has built an entire in-house manufacturing facility.

Mike Blankenstein, VP of patient supply operations, has been with the company for nearly five years, after 25 years of manufacturing and supply chain experience in a variety of industries. He provides strategic direction, leadership, and oversight of clinical and commercial supply planning and materials management for Adaptimmune’s global manufacturing and patient supply. Below, he discusses the company’s strategy for its cell therapy manufacturing facility and scaling up capacity.